Ming capital
Venture capitalShenzhen · Seed–Late Stage · 6 people tracked
Investment thesis
Ming Capital is a healthcare-focused venture capital firm dedicated to improving human health by backing medical breakthroughs, particularly in innovative medicine, medical devices, and in-vitro diagnostics. It aims to connect global resources across medical innovation, entrepreneurship, management, commercial markets, and capital markets through parallel onshore-offshore funds and parallel investments. The firm supports entrepreneurs developing world-leading technologies and invests across geographies including China, the US, Israel, and Europe.
Source: firm website, verified Aug 7, 2026.
Team · 6 people
from the firm's website & public directoriesWhat they invest in
from 8 of 16 portfolio companiesHardware ×5Medical Devices ×5Healthtech ×4Deep Tech ×2Media & Entertainment ×2Biotech ×1Fintech ×1Robotics ×1
HQs:China×4
Investments · 16 tracked
founders shown can be your intro pathGuangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.
Wuhan-area developer of oncolytic virus immunotherapy in China.
QQ.com is a Chinese web portal and content platform operated by Tencent that aggregates news, entertainment, gaming, and other digital services.
Media & EntertainmentShenzhen, CN
Co-investorsChina Growth CapitalChina Impact VenturesFirstCheck AfricaMonolith Venture Advisory LimitedSource Code Capital
Caretaker Medical builds VitalStream ART, a multi-modal device for continuous beat-to-beat hemodynamic monitoring that supports both invasive arterial-line and non-invasive wearable methods on a single platform.
HardwareHealthtechMedical Devices
Co-investorsEarly Light VenturesIrishAngelsRiptide Ventures
Exit; company using proprietary deep packet inspection (DPI) technology to help Chinese local internet network owners monitor and monetize network access points.
Edadoc (Yibo) is a Chinese electronics engineering services company focused on PCB design, high-speed circuit layout, and related hardware development support.
Deep TechHardwareRoboticsShenzhen, CN
EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.
BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsF-Prime Capital
Chengdu-based developer of AAV-based gene therapies for conditions such as AMD and XLRS.
Gordian Surgical develops the TroClose, an FDA-cleared integrated trocar and wound closure device that combines laparoscopic port access with automated port-site closure.
HardwareMedical Devices
Co-investorsTrendlines Group
Human Xtensions develops HandX, a handheld surgical device with detachable single-use instruments intended to bridge the gap between laparoscopic and robotic surgery.
HardwareHealthtechMedical Devices
Exit; medical device company developing cerebral embolic protection (CEP) devices to reduce stroke risk.
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Co-investorsDelta Partners
Exit; technology company providing automatic identification products, IoT mobile products, and enterprise mobile application services.
Ophthalmic technology company founded in Silicon Valley in 2014, now operating across Silicon Valley, Shanghai, and Luoyang.
PEdaily (投资界) is a Chinese online media platform published by Zero2IPO Group that reports on venture capital, private equity, startup fundraising, IPOs, and M&A.
FintechMedia & Entertainment
Co-investorsFortune Venture Capital
Frequently asked questions
- How many investments has Ming capital made?
- Ming capital has 16 tracked investments.
- What stage does Ming capital invest at?
- Ming capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Ming capital focus on?
- Ming capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics.
- Where is Ming capital located?
- Ming capital is headquartered in Shenzhen, CN.
- Who does Ming capital co-invest with?
- Ming capital most often shares deals with China Growth Capital, Early Light Ventures, F-Prime Capital, among 13 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.